Universal Ibogaine Inc. (IBOGF)
USD 0.02
(-11.05%)
USD 0.02
(-11.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -4.6 Million CAD | -22.43% |
| 2021 | -3.76 Million CAD | -589944.51% |
| 2020 | 638.00 CAD | 101.88% |
| 2019 | -33.86 Thousand CAD | -152.95% |
| 2018 | 63.95 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -736.54 Thousand CAD | -1.04% |
| 2023 Q1 | -728.96 Thousand CAD | 34.93% |
| 2023 Q3 | -346.66 Thousand CAD | 52.93% |
| 2022 Q4 | -1.12 Million CAD | -4.37% |
| 2022 FY | - CAD | -22.43% |
| 2022 Q3 | -1.07 Million CAD | -16.03% |
| 2022 Q2 | -925.11 Thousand CAD | 37.85% |
| 2022 Q1 | -1.48 Million CAD | -7964.19% |
| 2021 Q3 | 60.36 Thousand CAD | 984.58% |
| 2021 FY | - CAD | -589944.51% |
| 2021 Q1 | 31.26 Thousand CAD | -19.76% |
| 2021 Q4 | -18.45 Thousand CAD | -130.58% |
| 2021 Q2 | 5566.00 CAD | -82.19% |
| 2020 Q1 | 4987.00 CAD | 133.42% |
| 2020 Q2 | -4393.00 CAD | -188.09% |
| 2020 Q4 | 38.95 Thousand CAD | 164.8% |
| 2020 FY | - CAD | 101.88% |
| 2020 Q3 | 14.71 Thousand CAD | 434.9% |
| 2019 Q3 | -13.02 Thousand CAD | -215.0% |
| 2019 FY | - CAD | -152.95% |
| 2019 Q4 | -14.92 Thousand CAD | -14.61% |
| 2019 Q2 | 11.32 Thousand CAD | 221.37% |
| 2019 Q1 | -9329.00 CAD | 59.14% |
| 2018 Q2 | 64.69 Thousand CAD | 136.15% |
| 2018 Q1 | -178.95 Thousand CAD | -85.51% |
| 2018 Q3 | -41.41 Thousand CAD | -164.02% |
| 2018 Q4 | -22.83 Thousand CAD | 44.87% |
| 2018 FY | - CAD | 0.0% |
| 2017 Q4 | -96.47 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Evofem Biosciences, Inc. | -17.37 Million USD | 73.475% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -18.615% |
| CSL Limited | 4.78 Billion USD | 100.096% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 104.899% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -391.744% |
| BioStem Technologies, Inc. | -7.55 Million USD | 39.004% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -163.28% |
| Qrons Inc. | -40.08 Thousand USD | -11395.202% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 973.55% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 91.674% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 35.662% |
| Skye Bioscience, Inc. | -13.54 Million USD | 65.991% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -1154.665% |
| Rebus Holdings, Inc. | -951 Thousand USD | -384.479% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 70.967% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Genscript Biotech Corporation | -248.71 Million USD | 98.148% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -628.55% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 93.514% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 22.289% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -1826.57% |
| SQZ Biotechnologies Company | -64.14 Million USD | 92.817% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -74.229% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -199.951% |
| Mesoblast Limited | -62.38 Million USD | 92.615% |
| Marizyme, Inc. | -34.28 Million USD | 86.56% |
| Genus plc | 73.7 Million USD | 106.252% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 30.313% |
| Pharming Group N.V. | 9.87 Million USD | 146.648% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -209.759% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -29.896% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 47.476% |
| ContraFect Corporation | -64.99 Million USD | 92.912% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -1.794% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -228.675% |
| IMV Inc. | -35.52 Million USD | 87.03% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -98.268% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -789.379% |
| ONE Bio Corp. | 13.61 Million USD | 133.845% |
| Accustem Sciences Inc. | -3.74 Million USD | -22.981% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 90.446% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -263.608% |
| Q BioMed Inc. | -617.62 Thousand USD | -645.982% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 228.986% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -101.682% |
| Biomind Labs Inc. | -1.03 Million USD | -345.353% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 88.376% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -59.297% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 68621.594% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -18329.568% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -84.151% |
| GB Sciences, Inc. | -1.41 Million USD | -224.491% |
| Alpha Cognition Inc. | -9.7 Million USD | 52.529% |
| HST Global, Inc. | -5303.00 USD | -86782.746% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -123.986% |
| Halberd Corporation | -74.27 Thousand USD | -6102.819% |
| Enzolytics Inc. | -2.12 Million USD | -117.122% |
| Agentix Corp. | -1.37 Million USD | -235.875% |
| Resverlogix Corp. | -11.74 Million USD | 60.761% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -50.42% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | 97.867% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 478.586% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 152.039% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -207.384% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 1316.171% |
| AVAX Technologies, Inc. | -6.11 Million USD | 24.625% |
| Zenith Capital Corp. | -8.6 Million USD | 46.463% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -26347.345% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -88.329% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -2517.474% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -139.855% |
| Kadimastem Ltd | -2.62 Million USD | -75.561% |
| Helix BioMedix, Inc. | -1.04 Million USD | -340.346% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -2444.283% |
| LadRx Corporation | 412.28 Thousand USD | 1217.531% |
| Cell Source, Inc. | -4.27 Million USD | -7.838% |
| Regen BioPharma, Inc. | 1.46 Million USD | 414.293% |
| NovAccess Global Inc. | -1.03 Million USD | -345.246% |
| Affymax, Inc. | -14.29 Million USD | 67.769% |
| Itoco Inc. | -1.86 Million USD | -146.517% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -1113.685% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -312.849% |
| Mobile Lads Corp. | -2.24 Million USD | -105.581% |
| CytoDyn Inc. | -18.02 Million USD | 74.445% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -5730.002% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -37575.951% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -848.652% |
| SYBLEU INC | -141.57 Thousand USD | -3154.474% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -333.837% |
| International Stem Cell Corporation | 202 Thousand USD | 2380.887% |
| Bioxytran, Inc. | -3.82 Million USD | -20.608% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -8652.644% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -87.145% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 87.155% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -10138.649% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -68.276% |
| Neutra Corp. | -181.24 Thousand USD | -2442.051% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 77.145% |
| PureTech Health plc | -11.62 Million USD | 60.373% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 77.143% |
| IXICO plc | -707 Thousand USD | -551.682% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 40.047% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 90.47% |
| CSL Limited | 4.73 Billion USD | 100.097% |
| Cellectis S.A. | -92.63 Million USD | 95.026% |